Impact of LVAD Infections on Healthcare Costs and Antibiotic Use
Author Information
Author(s): Ficinski Matthew, West Jennifer, Glassman Shannon, Wojciechowski Katrina, Gutowski Jennifer, Laguio-Vila Maryrose, Feitell Scott, Lesho Emil
Primary Institution: Rochester Regional Health
Hypothesis
What is the burden of left ventricular assist device (LVAD) infections on healthcare costs, lengths of stay, and antibiotic resistance?
Conclusion
LVAD infections significantly increase healthcare costs, hospital stays, and antibiotic usage, with rising antimicrobial resistance linked to repeat infections.
Supporting Evidence
- Patients with LVAD infections had an average excess cost of $43,000 per event.
- One-third of infections occurred more than a year after LVAD implantation.
- Gram-negative and fungal organisms were more common in repeat infections.
Takeaway
Patients with LVADs can get infections that make them stay in the hospital longer and cost more money. These infections can also make the germs stronger and harder to treat.
Methodology
A prospective case-control study was conducted on 110 patients who received LVADs, monitoring them for infections and collecting data on costs and lengths of stay.
Potential Biases
Potential bias due to the single-center design and reliance on billing records for cost data.
Limitations
The study was conducted at a single center, limiting generalizability.
Participant Demographics
Patients included were those receiving LVADs for advanced heart failure, with a mix of demographics but specific details not provided.
Statistical Information
P-Value
0.06
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website